91 Results

People

  1. Ladanyi
    Ladanyi
  2. Paik
    Paik
  3. Weiser
    Weiser
  4. Riely
    Riely
  5. Drilon
    Drilon
  6. Kris
    Kris
  7. Paty
    Paty
  8. Rekhtman
    Rekhtman
  9. Yu
    Yu
  10. Arcila
    Arcila

Groups

  1. Department of Medicine (53)
  2. Solid Tumor Oncology Division (47)
  3. GSK Faculty (30)
  4. Human Oncology and Pathogenesis Program (27)
  5. Department of Pathology and Laboratory Medicine (26)
  6. Thoracic Oncology (26)
  7. Surgery (23)
  8. Tow Center for Developmental Oncology (TCDO) (19)
  9. Sloan Kettering Institute Postdocs (13)
  10. Genitourinary Oncology Service (12)
  1. "scatter factor receptor"
Formats
  1. Journal Article (79)
  2. Review (7)
  3. Correspondence (2)
  4. Editorial (2)
  5. Conference Paper (1)
Groups
  1. Department of Medicine (53)
  2. Solid Tumor Oncology Division (47)
  3. GSK Faculty (30)
  4. Human Oncology and Pathogenesis Program (27)
  5. Department of Pathology and Laboratory Medicine (26)
  6. Thoracic Oncology (26)

More Groups

People
  1. Marc Ladanyi (10)
  2. Paul Paik (10)
  3. Martin Weiser (7)
  4. Gregory Riely (6)
  5. Alexander Drilon (5)
  6. Helena Yu (5)

More People

Years
  1. 2025 (4)
  2. 2024 (7)
  3. 2023 (6)
  4. 2022 (4)
  5. 2021 (1)
  6. 2020 (8)

More Years

Publications
  1. Clinical Cancer Research (9)
  2. Proceedings of the National Academy of Sciences of the United States of America (5)
  3. Annals of Oncology (4)
  4. Cancer Discovery (3)
  5. Clinical Lung Cancer (3)
  6. Journal of Thoracic Oncology (3)

More Publications

Publishers
  1. American Association for Cancer Research (18)
  2. Elsevier Inc. (11)
  3. Elsevier Science, Inc. (8)
  4. Nature Publishing Group (7)
  5. Oxford University Press (7)
  6. National Academy of Sciences (5)

More Publishers

Results (91)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Are we trumping bone disease in prostate cancer? The Rove/Crawford article reviewed [Evolution of treatment options for patients with CRPC and bone metastases: Bone-targeted agents that go beyond palliation of symptoms to improve overall survival]
    Journal Article

    Slovin, S. F.
    Oncology (Norwalk) (2011)

    Fulltext@MSK | Save
  • Pancreatic cancer: The role of molecular markers in diagnosis and management
    Journal Article

    Lowery, M. A.; O'Reilly, E. M.
    Clinical Advances in Hematology & Oncology (2011)

    Fulltext@MSK | Save
  • Rethinking ovarian cancer: Recommendations for improving outcomes
    Journal Article

    Vaughan, S.; Coward, J. I.; Bast, R. C.; Berchuck, A.; Berek, J. S.; Brenton, J. D.; Coukos, G.; Crum, C. C.; Drapkin, R.; Etemadmoghadam, D.; more...
    Nature Reviews Cancer (2011)

    Fulltext@MSK | Save
  • Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutations
    Journal Article

    Rosell, R.; Molina, M. A.; Costa, C.; Simonetti, S.; Gimenez-Capitan, A.; Bertran-Alamillo, J.; Mayo, C.; Moran, T.; Mendez, P.; Cardenal, F.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Therapeutic implications of the emerging molecular biology of uveal melanoma
    Journal Article

    Patel, M.; Smyth, E.; Chapman, P. B.; Wolchok, J. D.; Schwartz, G. K.; Abramson, D. H.; Carvajal, R. D.
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification
    Journal Article

    Ou, S. H. I.; Kwak, E. L.; Siwak-Tapp, C.; Dy, J.; Bergethon, K.; Clark, J. W.; Camidge, D. R.; Solomon, B. J.; Maki, R. G.; Bang, Y. J.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • MET expression and amplification in patients with localized gastric cancer
    Journal Article

    Janjigian, Y. Y.; Tang, L. H.; Coit, D. G.; Kelsen, D. P.; Francone, T. D.; Weiser, M. R.; Jhanwar, S. C.; Shah, M. A.
    Cancer Epidemiology Biomarkers and Prevention (2011)

    Fulltext@MSK | Save
  • Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy
    Journal Article

    Brevet, M.; Shimizu, S.; Bott, M. J.; Shukla, N.; Zhou, Q.; Olshen, A. B.; Rusch, V.; Ladanyi, M.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay
    Journal Article

    Arcila, M. E.; Oxnard, G. R.; Nafa, K.; Riely, G. J.; Solomon, S. B.; Zakowski, M. F.; Kris, M. G.; Pao, W.; Miller, V. A.; Ladanyi, M.
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradation
    Journal Article

    Vivanco, I.; Rohle, D.; Versele, M.; Iwanami, A.; Kuga, D.; Oldrini, B.; Tanaka, K.; Dang, J.; Kubek, S.; Palaskas, N.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2010)

    Fulltext@MSK | Save